NASDAQ: INOInovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?
Insider buying vs selling
Have Inovio Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael John Sumner | Chief Medical Officer | 2025-05-15 | 680 | $1.95 | $1.33kSell |
| Laurent Humeau | Chief Scientific Officer | 2025-05-15 | 1,708 | $1.95 | $3.33kSell |
| Peter Kies | CFO | 2025-05-15 | 2,566 | $1.95 | $5.00kSell |
| Jacqueline Elizabeth Shea | Chief Executive Officer | 2025-05-15 | 7,717 | $1.95 | $15.05kSell |
| Jacqueline Elizabeth Shea | Chief Executive Officer | 2025-05-10 | 2,392 | $1.80 | $4.31kSell |
| Laurent Humeau | Chief Scientific Officer | 2025-02-26 | 1,584 | $1.98 | $3.14kSell |
| Jacqueline Elizabeth Shea | Chief Executive Officer | 2025-02-26 | 2,493 | $1.98 | $4.94kSell |
| Peter Kies | CFO | 2025-02-26 | 2,960 | $1.98 | $5.86kSell |
| Laurent Humeau | Chief Scientific Officer | 2025-02-26 | 2,059 | $1.98 | $4.08kSell |
| Peter Kies | CFO | 2025-02-26 | 2,362 | $1.98 | $4.68kSell |
INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INO insiders and whales buy or sell their stock.
INO Shareholders
What type of owners hold Inovio Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Austin W. Greenhouse David M. Marxe | 38.86% | 20,650,987 | $49.15M | Insider |
| Tee Khiang Ng | 9.22% | 4,899,931 | $11.66M | Insider |
| Jong Joseph Kim | 4.41% | 2,346,000 | $5.58M | Insider |
| Vanguard Group Inc | 3.78% | 2,009,145 | $4.78M | Institution |
| Deep Track Capital LP | 3.73% | 1,981,370 | $4.72M | Institution |
| Bank Of America Corp | 2.39% | 1,270,607 | $3.02M | Institution |
| Beng Lee Gan | 1.55% | 823,045 | $1.96M | Insider |
| Kevin Rassas | 1.37% | 726,088 | $1.73M | Insider |
| Blackrock Inc | 1.01% | 537,628 | $1.28M | Institution |
| Geode Capital Management LLC | 0.82% | 437,549 | $1.04M | Institution |
INO vs Biotech Stocks
Inovio Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.